Chief of Staff to Chief Commercial Officer

Responsibilities

• Serve as a strategic thought partner to the Chief Commercial Officer (CCO) to increase leadership leverage
• Facilitate information flow and ensure cross-functional alignment across the commercial executive leadership team
• Lead key strategic initiatives, including preparations for upcoming commercial launches
• Organize, interpret, and present complex data to inform strategic decision-making
• Manage the operating rhythm of the Office of the CCO and prepare materials for the Board of Directors
• Respond to urgent issues and coordinate cross-functional efforts to resolve emerging challenges
• Synthesize complex topics into succinct, high-quality slide presentations

Requirements

• 3 to 6+ years of relevant business development, operations, or strategy experience in biopharma
• Proven familiarity with drug discovery, development, and commercialization processes
• Exceptional written communication and presentation skills with the ability to distill complexity
• Expertise in ChatGPT, Claude, Excel, and PowerPoint
• Ability to operate effectively in ambiguous environments and drive follow-through without formal authority
• Strong analytical skills and a structured approach to problem-solving

Preferred Qualifications

• 2 to 3 years of experience in a top-tier professional services firm (e.g., consulting or banking)
• Graduate degree in a relevant field

Benefits

• Market-leading compensation and employee stock purchase program
• 100% employer-paid medical, dental, and vision premiums for employees and dependents
• 401(k) with employer match
• Unlimited flexible paid time off and paid parental leave
• Comprehensive mental health support and professional development programs

About the Company

BridgeBio is a commercial-stage biopharmaceutical company dedicated to discovering and delivering transformative medicines for patients with genetic diseases. By bridging the gap between academic genetic science and clinical delivery, BridgeBio has built a robust portfolio of over 30 drug development programs across multiple therapeutic areas.